Sera Operating Margin from 2010 to 2026
| SERA Stock | USD 2.60 0.05 1.89% |
Check Sera Prognostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sera Prognostics' main balance sheet or income statement drivers, such as Net Interest Income of 3.3 M, Interest Income of 3.3 M or Depreciation And Amortization of 665.2 K, as well as many indicators such as Price To Sales Ratio of 3.9 K, Dividend Yield of 0.0 or PTB Ratio of 6.17. Sera financial statements analysis is a perfect complement when working with Sera Prognostics Valuation or Volatility modules.
Sera | Operating Margin | Build AI portfolio with Sera Stock |
Analyzing Sera Prognostics's Operating Margin over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Operating Margin has evolved provides context for assessing Sera Prognostics's current valuation and future prospects.
Latest Sera Prognostics' Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Sera Prognostics over the last few years. It is Sera Prognostics' Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sera Prognostics' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (561.25) % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Sera Operating Margin Regression Statistics
| Arithmetic Mean | (435.82) | |
| Coefficient Of Variation | (28.79) | |
| Mean Deviation | 68.58 | |
| Median | (460.44) | |
| Standard Deviation | 125.49 | |
| Sample Variance | 15,747 | |
| Range | 589 | |
| R-Value | 0.26 | |
| Mean Square Error | 15,690 | |
| R-Squared | 0.07 | |
| Significance | 0.32 | |
| Slope | 6.38 | |
| Total Sum of Squares | 251,948 |
Sera Operating Margin History
About Sera Prognostics Financial Statements
Sera Prognostics stakeholders use historical fundamental indicators, such as Sera Prognostics' Operating Margin, to determine how well the company is positioned to perform in the future. Although Sera Prognostics investors may analyze each financial statement separately, they are all interrelated. For example, changes in Sera Prognostics' assets and liabilities are reflected in the revenues and expenses on Sera Prognostics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Sera Prognostics. Please read more on our technical analysis and fundamental analysis pages.
Sera Prognostics, Inc., a womens health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah. Sera Prognostics operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 113 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Sera Prognostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sera Prognostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sera Prognostics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sera Prognostics Stock:Check out the analysis of Sera Prognostics Correlation against competitors. For information on how to trade Sera Stock refer to our How to Trade Sera Stock guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sera Prognostics. If investors know Sera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Sera Prognostics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.76) | Revenue Per Share | Quarterly Revenue Growth (0.45) | Return On Assets | Return On Equity |
Understanding Sera Prognostics requires distinguishing between market price and book value, where the latter reflects Sera's accounting equity. The concept of intrinsic value - what Sera Prognostics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Sera Prognostics' price substantially above or below its fundamental value.
Please note, there is a significant difference between Sera Prognostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sera Prognostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Sera Prognostics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.